kampirone has been researched along with Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbhaiya, RH; Gammans, RE; Laroudie, C; Pfeffer, M; Pittman, KA; Shrotriya, R; Shukla, UA | 1 |
| Caccia, S; Gammans, RE; Garattini, S; Mayol, RF; Mingardi, G; Pfeffer, M; Placchi, M; Vigano, GL | 1 |
1 trial(s) available for kampirone and Kidney Diseases
| Article | Year |
|---|---|
Disposition kinetics of buspirone in patients with renal or hepatic impairment after administration of single and multiple doses.
Topics: Adult; Anti-Anxiety Agents; Buspirone; Female; Humans; Kidney Diseases; Liver Cirrhosis; Liver Diseases; Male; Middle Aged | 1994 |
1 other study(ies) available for kampirone and Kidney Diseases
| Article | Year |
|---|---|
Clinical pharmacokinetics of oral buspirone in patients with impaired renal function.
Topics: Administration, Oral; Adult; Buspirone; Humans; Kidney; Kidney Diseases; Kidney Failure, Chronic; Kinetics; Male; Middle Aged | 1988 |